Mycoplasma pneumonia historical perspective
|
Mycoplasma pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mycoplasma pneumonia historical perspective On the Web |
|
American Roentgen Ray Society Images of Mycoplasma pneumonia historical perspective |
|
Risk calculators and risk factors for Mycoplasma pneumonia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
In humans, Mycoplasma pneumoniae was first described by Hobart A. Reimann in 1938 in a patient with a self-limited “atypical” pneumonia.
Historical Perspective
- Mycoplasma pneumoniae was first described by Hobart A. Reimann in 1938 in a patient with a self-limited “atypical” pneumonia.[1]
- In 1943, Reimann first described the phenomenon of cold agglutination.
- It was first thought to be a virus or fungus, which is why the organism is referred to as Mycoplasma (Greek for “fungus-formed”).
- In 1944, Eaton reported Eaton's agent as the primary cause of atypical pneumonia.[2] In 1961, M. pneumoniae was discovered to be Eaton's agent.
References
- ↑ Reimann HA (1984). "Landmark article Dec 24,1938: An acute infection of the respiratory tract with atypical pneumonia. A disease entity probably caused by a filtrable virus. By Hobart A. Reimann". JAMA. 251 (7): 936–44. PMID 6363732.
- ↑ Eaton MD, Meiklejohn G, van Herick W (1944). "STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : A FILTERABLE AGENT TRANSMISSIBLE TO COTTON RATS, HAMSTERS, AND CHICK EMBRYOS". J Exp Med. 79 (6): 649–68. PMC 2135382. PMID 19871393.